Abstract
Aim
This investigation newly describes the characteristics and treatment for a group of patients with inactive thyroid eye disease who presented with recurrent transient visual obscuration, generally related to sudden changes in posture.
Study design
A retrospective case-note review of an unmatched case series.
Patients and methods
Clinical records were reviewed for patients with thyroid eye disease, presenting to the Orbital Clinic at Moorfields Eye Hospital with recurrent transient visual obscuration. All patients underwent orbital decompression and the response to this, and other, treatment was reviewed.
Results
Six patients (five female) presented to the Orbital Clinic, between the ages of 43 and 66 years (mean 54.7; median 52 years), with recurrent visual obscurations related to postural changes. Transient obscurations had been noted for between 3 weeks and 2 months, the patients having had symptoms of underlying thyroid eye disease for between 6 and 18 months. Five patients had diabetes for between 2 and 45 years, four being controlled with insulin and one with metformin. All patients had increased orbital tension on clinical assessment, intraocular pressures were raised in 5/6, and the optic disc in affected eyes was markedly swollen (with bilateral choroidal folds in two patients). Hertel exophthalmometry ranged from 22 to 27 mm, and there was a global reduction in ocular ductions in all. Bilateral orbital decompression was performed in all patients, although sequentially in one patient: 4/6 patients had three-wall decompression with an average proptosis reduction of 5.8 mm (range 2–8 mm; eight orbits) and 2/6 had decompression of the medial wall and floor alone (mean reduction 6.8 mm, range 5–8 mm; four orbits). In all patients, there was an almost immediate cessation of obscurations, together with a subjective and objective improvement in various visual functions. Optic disc swelling resolved over a few weeks after surgery.
Conclusion
The ‘hydraulic’ variant of thyroid eye disease—characterised by high orbital apex pressures, with secondarily raised episcleral venous and intraocular pressures—may be linked with certain orbital shapes, such as that of Asians. This variant can present with recurrent visual obscuration associated with transient postural hypotension, especially in diabetics—this possibly being due to a microvasculopathy of the orbital or optic nerve circulation.
Similar content being viewed by others
Introduction
Thyroid optic neuropathy arises from tissue crowding in the posterior one-third of the orbit, this typically being due to muscular enlargement,1, 2 and surgical relief of neuropathy necessitates bone removal and periosteal opening at the orbital apex.1, 2, 3, 4, 5 Although increased apical pressure will inevitably raise episcleral venous pressure, this is only rarely manifested as episcleral vascular dilation. Some patients with inactive thyroid eye disease and mild proptosis, however, have a markedly increased orbital pressure that can be associated with deep orbital vascular congestion, persistently raised intraocular pressures and, in some cases, optic neuropathy.2, 6 This congestive variant—termed ‘hydraulic’ disease by the writer, to distinguish it from the congestion of the active inflammatory phase—appears commoner with certain races (particularly Asians7, 8), this probably being due to their thicker orbital walls and relatively less compliant orbital septum.
This paper presents a typical case of hydraulic thyroid eye disease, treated effectively with three-wall orbital decompression, and also newly describes the clinical characteristics for a group of such patients presenting with transient visual obscuration during periods of postural hypotension.
Patients and methods
A retrospective review of clinical records was undertaken for patients presenting with repeated transient visual obscuration in association with inactive thyroid eye disease; the patients being identified from the Orbital Clinic database at Moorfields Eye Hospital.
All patients had full ophthalmic assessment and appropriate orbital imaging. The orbital congestion was treated by orbital decompression, performed through a lower-lid swinging flap approach, with complete removal of the bone and periorbita from the medial wall and the medial half of the orbital floor. Where a greater reduction in proptosis was required, the decompression was extended to include a large window in the lateral orbital wall and additional removal of the floor over, and lateral to, the infraorbital nerve.
Results
Case reports
‘Hydraulic’ thyroid eye disease
A 68-year-old male presented with 12 months of ocular inflammation, treated with systemic steroids and orbital radiotherapy, the symptoms having increased 3 months prior to referral—with bilateral periocular oedema and slight blurring of vision. Thyrotoxicosis had been medically treated 2 years before and the patient had received radioiodine a year later—with onset of ocular redness, irritability and watering. The patient was referred while taking 80 mg systemic prednisolone daily for his thyroid eye disease, together with topical latanoprost and betaxolol.
The Snellen acuity at referral was 6/6 right and 6/36 left (in a densely amblyopic eye), with normal right Ishihara colour perception and no relative afferent pupillary defect (RAPD). There was no clinical evidence of orbital inflammation, extremes of ocular ductions were moderately limited, Hertel exophthalmometry was 27 mm in each eye, and there were gross cheek festoons of congestive oedema (Figure 1a). Both eyes showed marked episcleral venous congestion and the intraocular pressures on treatment were 19 mmHg right and 23 mmHg left (Figure 1b). Orbital CT demonstrated bilateral proptosis, with diffuse muscular enlargement and vascular congestion (Figure 1c and d).
After bilateral three-wall orbital decompression, episcleral venous congestion disappeared over a few weeks (Figure 2b), intraocular pressures—off all topical medications—returned to normal range, and the gross periocular oedema resolved slowly over a year (Figure 2a).
Case 1
A 42-year-old male, insulin-dependent diabetic for 12 years, was referred with a 6 month history of irritable, red eyes; a diagnosis of thyrotoxicosis and thyroid eye disease had been made 3 months prior to referral and treated with carbimazole, systemic steroids and methotrexate.
His vision had deteriorated over 3 weeks prior to referral, with increasing diplopia, and the patient had noted that the sight in both eyes frequently ‘faded out’ on getting up from a chair or bed: The visual loss occurred on bending or rapidly changing position, appearing as a rapid ‘blacking out’ of the visual field, with the eyesight returning after about 15–20 s. The patient had never experienced visual symptoms prior to the onset of thyroid eye disease, and did not have any overt symptoms or signs of systemic hypertension, diabetic vasculopathy or prior postural hypotension and syncope.
The acuity at first referral was Snellen 6/9 right and 6/12 left, with moderately impaired colour perception and a mild left RAPD. Both orbits were extremely tense, with bilateral Hertel exophthalmometry of 23 mm, and there was gross impairment of ocular movements (Figure 3a). The optic discs were markedly swollen (Figure 3b), the retinal and episcleral veins congested, and the intraocular pressures were 25 mmHg right and 31 mmHg left on downgaze (rising to 43 and 56 mmHg on attempted upgaze).
Although there was an improvement in acuity to 6/9 right and 6/6 left, with disappearance of the left RAPD, after 3 days of systemic methylprednisolone (1 g daily), there was persistence of the gross optic disc swelling and the transient visual obscurations. The patient therefore underwent bilateral three-wall decompression, with complete disappearance of the postural obscurations from the day after surgery, normal Ishihara colour perception within a week, resolution of disc swelling over 3–4 weeks (Figure 4) and disappearance of the episcleral venous congestion (with return of intraocular pressures to normal) over about 6 months.
Case 2
A nonsmoking 51-year-old diabetic woman (on insulin for 2 years) was referred with an 8 month history of bilateral eyelid swelling treated with systemic steroids and methotrexate; she had thyrotoxicosis, treated with radio-iodine, about 9 months before onset of eye symptoms. For a month prior to referral, the patient had noted transient ‘blackouts of vision’, occurring in both eyes for several seconds, on rapid standing or on bending.
The patient's acuity at referral was 6/18 right and 6/24 left, with good right and fair left colour perception (Figure 5a). There was moderate exophthalmos (Hertel 25 mm right, 27 mm left), orbits that were very resistant to retropulsion, and a gross restriction of eye movements. Intraocular pressures were 30 mmHg right and 28 mmHg left, with a mild rise on attempted upgaze. Bilateral optic disc swelling and choroidal striae were evident (Figure 5b) and orbital CT showed large recti (Figure 5c) and gross vascular engorgement (Figure 5d).
Three-wall orbital decompression resulted in immediate cessation of visual obscurations and the disc swelling and choroidal folds cleared over 2–3 weeks after surgery; intraocular pressure control remained variable and the left visual acuity remained somewhat reduced due to herpetic kerato-uveitis.
Group characteristics
Six patients (five female; 83%) had recurrent obscuration of vision on sudden changes of posture, these obscurations presenting as a rapid ‘blacking out’ of visual field with a recovery over 20–30 s. The patients were aged between 43 and 66 years (mean 54.7, median 52 years) and had noticed obscurations for between 3 weeks and 2 months, often in association with a subjective reduction in visual acuity and colour discrimination; all had prior signs and symptoms of active thyroid eye disease for between 6 and 18 months, for which they had received systemic immunosuppression and, in 5/6 cases, topical therapy for moderately or markedly raised intraocular pressures (Table 1). Four of the six patients had thyrotoxicosis, this being only 1–2 years before onset of orbital disease, whereas the 2/6 with primary myxoedema developed the thyroid condition 13 and 24 years before the eye disease (Table 1). Four patients had insulin-controlled diabetes, with the condition for 2, 12, 29, and 45 years, and one had a 2-year diagnosis of diabetes treated with metformin.
The acuity at presentation ranged from 6/9 to counting fingers (Table 1) and all patients had increased orbital tension on clinical assessment; intraocular pressures were raised to the high 20s and 30s (mmHg) in 5/6 patients – despite multiple therapy. The optic disc was markedly swollen in all affected orbits, with bilateral choroidal folds in two patients, and Hertel exophthalmometry ranged from 22 to 27 mm (Table 1). There was a global reduction in ocular ductions in all cases.
Bilateral orbital decompression was performed in all patients, although sequentially in one patient: 4/6 patients had three-wall decompression with an average proptosis reduction of 5.8 mm (range 2–8 mm; eight orbits) and 2/6 had decompression of the medial wall and floor alone (mean reduction 6.8 mm, range 5–8 mm; four orbits) (Table 2). In all patients there was an almost immediate cessation of obscurations, together with a subjective and objective improvement in various visual functions. Optic disc swelling resolved over a few weeks after surgery.
Four patients required long-term topical therapy for control of intraocular pressures, although in all cases fewer medications were required and pressure was better controlled than before surgery (to within normal range). Two patients required bilateral strabismus surgery for exacerbation of esotropia that had been present before decompression, with restoration of a good field of binocular single vision.
Discussion
Thyroid-related orbital inflammation leads to vasodilatation, leakage of intravascular fluid into the tissue and increasing orbital tissue pressure, especially within the confines of the orbital apex.1, 2 Deposition of extra ground substances (glycosaminoglycans; GAGs) within orbital tissues, together with post-inflammatory fibrosis, decreases tissue compliance—as has been eloquently demonstrated with in vivo manometry9 (Table 3). This decreased compliance—particularly when coupled with an unyielding orbital septum that prevents proptosis—might result in a sustained rise in orbital pressure, decreased tissue perfusion and impairing optic nerve function; there being a recognised inverse relationship between the degree of proptosis and the tendency to thyroid optic neuropathy. The tendency to optic neuropathy might be greater in Asian patients, in whom the orbital septum is less compliant and the orbital apex more confined by thick bone.7, 8
Some patients with high orbital pressures do not have overt optic neuropathy, but instead develop a marked episcleral venous congestion—resembling the arteriolised vessels of low-flow dural shunts—with chronically raised intraocular pressures, often on multiple therapy (Figure 1b). These clinical signs are frequently misinterpreted as active orbital inflammation, although this late, congestive phase of orbitopathy is well beyond the stage of active inflammation; this late stage being termed ‘hydraulic’ or ‘meta-active’ disease by the writer (Figure 6), thereby differentiating it from the acute congestion of active inflammation.
Among patients with meta-active, hydraulic disease, there appear some with borderline optic nerve perfusion—a blood flow that is only just able to maintain neuronal function (Figure 6). Such patients would seem to be liable to visual obscuration whenever there is a fall in systemic blood pressure due to postural change, diabetics appearing particularly susceptible to this phenomenon (Table 1). In all of these patients, the high orbital tissue pressure was associated with marked optic disc swelling (Figures 3b and 5b)—this suggesting a peripapillary vasculopathy, similar to diabetic papillopathy. The vascular embarrassment of the optic nerve (due to high intraorbital pressure) is very effectively relieved by orbital decompression and leads to an immediate cessation of postural visual obscurations.
References
Kennerdell JS, Rosenbaum AE, El-Hoshy MH . Apical optic nerve compression of dysthyroid optic neuropathy on computed tomography. Arch Ophthalmol 1988; 99: 807–809.
Neigel JM, Rootman J, Belkin RI, Nugent RA, Drance SM, Beattie CW et al. Dysthyroid optic neuropathy, the crowded orbital apex syndrome. Ophthalmology 1988; 95: 1515–1521.
Lucarelli MJ, Shore JW . Management of thyroid optic neuropathy. Int Ophthalmol Clin 1996; 36: 179–193.
Goldberg RA . The evolving paradigm of orbital decompression surgery. Arch Ophthalmol 1998; 116: 95–96.
Siracuse-Lee DE, Kazim M . Orbital decompression: current concepts. Curr Opin Ophthalmol 2002; 13: 310–316.
Nugent RA, Belkin RI, Neigel JM, Rootman J, Robertson WD, Spineui J et al. Graves' orbitopathy: correlation of CT and clinical findings. Radiology 1990; 177: 675–682.
Rootman J . Aspects of current management of thyroid orbitopathy in Asians. Asia Pac J Ophthalmol 1998; 10: 2–6.
Liao SL, Kao SCS, Hou PK, Chen MS . Results of orbital decompression in Taiwan. Orbit 2001; 20: 267–274.
Riemann CD, Foster JA, Kosmorsky GS . Direct orbital manometry in patients with thyroid-associated orbitopathy. Ophthalmology 1999; 106: 1296–1302.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rose, G. Postural visual obscurations in patients with inactive thyroid eye disease; a variant of ‘hydraulic’ disease. Eye 20, 1178–1185 (2006). https://doi.org/10.1038/sj.eye.6702381
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.eye.6702381